Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
04 2022
Historique:
revised: 17 11 2021
received: 20 10 2021
accepted: 24 11 2021
pubmed: 27 11 2021
medline: 25 2 2022
entrez: 26 11 2021
Statut: ppublish

Résumé

The rapid spread of the Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a serious concern worldwide in summer 2021. We examined the copy number and variant types of all SARS-CoV-2-positive patients who visited our hospital from February to August 2021 using polymerase chain reaction (PCR) tests. Whole genome sequencing was performed for some samples. The R.1 variant (B.1.1.316) was responsible for most infections in March, replacing the previous variant (B.1.1.214); the Alpha (B.1.1.7) variant caused most infections in April and May; and the Delta variant (B.1.617.2) was the most prevalent in July and August. There was no significant difference in the copy numbers among the previous variant cases (n = 29, median 3.0 × 10

Identifiants

pubmed: 34825717
doi: 10.1002/jmv.27479
pmc: PMC9015476
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1707-1710

Subventions

Organisme : Japan Agency for Medical Research and Development
Organisme : JST-CREST

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Euro Surveill. 2021 Jun;26(24):
pubmed: 34142653
Nat Genet. 2021 Nov;53(11):1606-1615
pubmed: 34737427
J Med Virol. 2021 Dec;93(12):6833-6836
pubmed: 34314050
J Med Virol. 2022 Apr;94(4):1707-1710
pubmed: 34825717
Cell Rep. 2022 May 17;39(7):110829
pubmed: 35550680
Clin Infect Dis. 2021 Aug 23;:
pubmed: 34423834
Fungal Syst Evol. 2021 Jun;7:133-164
pubmed: 34124621
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1255-1260
pubmed: 34499627
Lancet Infect Dis. 2021 Oct;21(10):1351
pubmed: 34487704

Auteurs

Chihiro Tani-Sassa (C)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Yumi Iwasaki (Y)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Naoya Ichimura (N)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Katsutoshi Nagano (K)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Yuna Takatsuki (Y)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Sonoka Yuasa (S)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Yuta Takahashi (Y)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Jun Nakajima (J)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Kazunari Sonobe (K)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Yoko Nukui (Y)

Infection Control and Prevention, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Hiroaki Takeuchi (H)

Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo, Japan.

Kousuke Tanimoto (K)

Genome Laboratory, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo, Japan.
Research Core, Institute of Research, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo, Japan.

Yukie Tanaka (Y)

Research Core, Institute of Research, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo, Japan.

Akinori Kimura (A)

Institute of Research, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo, Japan.

Shuji Tohda (S)

Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Bunkyo-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH